Myths vs facts: hsCRP and Wechseljahre

The topic of myths vs facts about hsCRP (high-sensitivity C-reactive protein) and menopause is important, as many women encounter this inflammatory marker during this life stage. Fact: hsCRP is a well-established biomarker for systemic inflammation and is used for cardiovascular risk assessment. During menopause, cardiovascular risk increases, and some studies show a rise in hsCRP, possibly due to estrogen decline and altered fat distribution. Myth: hsCRP is not a specific test for menopause or its symptoms. An elevated hsCRP can have many causes (infections, smoking, obesity) and should not be interpreted in isolation as an indicator of menopausal status. Evidence is based on observational studies; no randomized controlled trials demonstrate a direct benefit of hsCRP measurement for guiding menopause management. For consumers using home tests: hsCRP can be part of a cardiovascular screening, but interpretation requires medical guidance. A standalone hsCRP test does not replace comprehensive menopause diagnostics. Safety note: persistently elevated levels warrant medical evaluation to rule out inflammatory conditions.